课题基金 / 基金详情

TESTING OF KETACONAZOLE AS MALE CONTRACEPTIVE AGENTS

TESTING OF KETACONAZOLE AS MALE CONTRACEPTIVE AGENTS
酮康唑作为男性避孕药的测试
批准号：
3653278
负责人：
LUDWIG BAUER
金额：
$11.4万
依托单位：
UNIVERSITY OF ILLINOIS AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
1987
资助国家：
美国
项目状态：
已结题
起止时间：
1987-12-01 至 1990-11-30
来源：
https://reporter.nih.gov/project-details/3653278
关键词：
drug design /synthesis /production sperm motility spermatogenesis inhibitor

项目摘要

项目成果

LUDWIG BAUER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed research is a comprehensive, 36 month, synthetic and biological testing program aimed at the development of novel non-steroidal male contraceptive agents that will immobilize spermatozoa and that are related to ketoconazole, itraconazole and terconazole. The proposed research may lead to the development of new derivatives of ketoconazole, itraconazole and terconazole providing new, highly effective, and safe male contraceptive agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
海外基金